[Clinical studies with a new piperidyl-phenothiazine derivative (A 124)].
D000328:Adult; D000410:Alanine Transaminase / Q000097:blood; D001219:Aspartate Aminotransferases / Q000097:blood; D001321:Autistic Disorder / Q000188:drug therapy; D001341:Autonomic Nervous System / Q000187:drug effects; D002389:Catatonia / Q000188:drug therapy; D005260:Female; D006212:Hallucinations / Q000188:drug therapy; D006801:Humans; D006993:Hypnotics and Sedatives / Q000627:therapeutic use; D008111:Liver Function Tests; D008297:Male; D001523:Mental Disorders / Q000188:drug therapy* / Q000201:enzymology; D009325:Nausea / Q000139:chemically induced; D009497:Neurotic Disorders / Q000188:drug therapy; D010259:Paranoid Disorders / Q000188:drug therapy; D010554:Personality Disorders / Q000188:drug therapy; D010640:Phenothiazines / Q000009:adverse effects / Q000627:therapeutic use*; D010880:Piperidines / Q000009:adverse effects / Q000627:therapeutic use*; D012559:Schizophrenia / Q000188:drug therapy; D012893:Sleep Wake Disorders / Q000139:chemically induced; D013268:Stimulation, Chemical; D013546:Sweating; D014202:Tremor / Q000139:chemically induced; D014652:Vascular Diseases / Q000139:chemically induced; D014839:Vomiting / Q000139:chemically induced
D006993:Hypnotics and Sedatives; D010640:Phenothiazines; D010880:Piperidines; D001219:Aspartate Aminotransferases; D000410:Alanine Transaminase
Klinische Untersuchungen mit einem neuen Piperidyl-phenothiazin-Derivat (A 124)